CIRCULATION Co.,Ltd. Logo

CIRCULATION Co.,Ltd.

Connects corporations with experts for project-based consulting to solve business challenges.

7379 | T

Overview

Corporate Details

ISIN(s):
JP3310050004
LEI:
Country:
Japan
Address:
渋谷区神宮前三丁目21番5号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

CIRCULATION Co., Ltd. operates a professional sharing platform that provides consulting support services. The company's core business model connects corporations with a network of external, independent experts and professionals to solve specific management and operational challenges. Its primary service, 'Pro-sharing Consulting,' offers project-based access to specialized knowledge in areas such as new business development, growth strategy, and technology leadership. By creating a system for the circulation of experience and expertise, CIRCULATION aims to support corporate innovation, address complex business problems, and facilitate growth for its clients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-07 10:10
M&A Activity
意見表明報告書
Japanese 293.3 KB
2025-03-14 07:31
Interim Report
半期報告書-第12期(2024/08/01-2025/07/31)
Japanese 234.1 KB
2025-03-14 07:31
Interim Report
確認書
Japanese 8.7 KB
2024-12-19 08:00
Share Issue/Capital Change
臨時報告書
Japanese 35.0 KB
2024-10-30 07:00
Post-Annual General Meeting Information
臨時報告書
Japanese 24.5 KB
2024-10-29 07:03
Governance Information
内部統制報告書-第11期(2023/08/01-2024/07/31)
Japanese 22.6 KB
2024-10-29 07:02
Registration Form
確認書
Japanese 8.7 KB
2024-10-29 07:01
Registration Form
有価証券報告書-第11期(2023/08/01-2024/07/31)
Japanese 2.4 MB
2024-06-13 08:01
Registration Form
確認書
Japanese 8.8 KB
2024-06-13 08:00
Quarterly Report
四半期報告書-第11期第3四半期(2024/02/01-2024/04/30)
Japanese 160.8 KB
2024-06-06 04:30
Major Shareholding Notification
臨時報告書
Japanese 21.0 KB
2024-05-22 10:11
Major Shareholding Notification
訂正臨時報告書
Japanese 26.3 KB
2024-03-15 07:00
Report Publication Announcement
確認書
Japanese 8.8 KB
2024-03-15 07:00
Quarterly Report
四半期報告書-第11期第2四半期(2023/11/01-2024/01/31)
Japanese 192.2 KB
2024-03-12 07:00
Major Shareholding Notification
臨時報告書
Japanese 20.5 KB

Automate Your Workflow. Get a real-time feed of all CIRCULATION Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CIRCULATION Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CIRCULATION Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.